Modern Mobility Aids, Inc. announced an agreement with ACGT Corporation to combine its resources and expertise with Lumigene Technologies, Inc. (Lumigene) to develop and commercialize molecular diagnostic products. Modern Mobility Aids and Lumigene have agreed to extend the closing of the share purchase agreement to November 30, 2012 in order to focus all their resources in commercialization of the Lumigene products.